Edition:
United Kingdom

People: Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,655.55INR
11:10am BST
Change (% chg)

Rs-10.75 (-0.40%)
Prev Close
Rs2,666.30
Open
Rs2,665.25
Day's High
Rs2,679.85
Day's Low
Rs2,630.00
Volume
434,455
Avg. Vol
686,686
52-wk High
Rs2,964.00
52-wk Low
Rs1,872.95

Reddy, Satish 

Mr. Satish K. Reddy serves as a Chairman of the Board of the Company. Mr. K Satish Reddy joined the company in 1993 as Executive Director and since then has held positions of increasing responsibility as Managing Director in 1997 and Vice-Chairman & Managing Director in 2013. Mr. Reddy led the company’s transition from a uni-focused manufacturer of Active Pharmaceutical Ingredients (APIs) to a company that moved up the value chain with a diverse product portfolio of fi nished dosage formulations. He oversaw the expansion and the establishment of a strong footprint for Dr. Reddy’s fi nished dosage products in Russia, CIS countries and other emerging markets. Keeping true to the legacy of the founder of the company, Dr. K Anji Reddy, Mr. K Satish Reddy drives the company’s Corporate Social Responsibility initiatives. Mr. Reddy holds a degree in Chemical Engineering from Osmania University, Hyderabad and a Masters in Medicinal Chemistry from Purdue University, USA.

Basic Compensation

Total Annual Compensation, INR 69,315,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 69,315,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Satish Reddy

69,315,000

G. Prasad

93,515,000

Saumen Chakraborty

39,930,000

MARC KIKUCHI

--

M. Ramana

--

Erez Israeli

--
As Of  31 Mar 2019